BIOMAT Database Logo BIOMAT Database Logo

[Thrombolytic preparations and anticoagulants in the treatment of patients with thrombotic stroke]. 1974

S G Koniukhov, and S P Liberzon

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

S G Koniukhov, and S P Liberzon
Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
January 2012, Cerebrovascular diseases (Basel, Switzerland),
S G Koniukhov, and S P Liberzon
Thrombolytic intervention in acute thrombotic and embolic stroke.
January 1993, Zeitschrift fur Kardiologie,
S G Koniukhov, and S P Liberzon
Thrombolytic intervention in acute thrombotic and embolic stroke.
December 1991, Seminars in neurology,
S G Koniukhov, and S P Liberzon
Incidental Thrombotic Thrombocytopenic Purpura during Acute Ischemic Stroke and Thrombolytic Treatment.
May 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
S G Koniukhov, and S P Liberzon
[Treatment of patients with acute coronary insufficiency with thrombolytic preparations (fibrinolysin and thrombolytin)].
December 1968, Terapevticheskii arkhiv,
S G Koniukhov, and S P Liberzon
Intravenous Thrombolytic Therapy for Treatment of Acute Ischemic Stroke in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants.
February 2022, JAMA,
S G Koniukhov, and S P Liberzon
Should more patients with acute ischaemic stroke receive thrombolytic treatment?
November 2009, BMJ (Clinical research ed.),
S G Koniukhov, and S P Liberzon
Thrombolytic agents and anticoagulants.
November 1993, Cardiovascular drugs and therapy,
S G Koniukhov, and S P Liberzon
Thrombolytic agents in the treatment of stroke.
August 1990, Clinical neuropharmacology,
S G Koniukhov, and S P Liberzon
Thrombolytic therapy in the treatment of stroke.
January 1997, Drugs,
Copied contents to your clipboard!